Our studies have succeeded in establishing an EEG and behavioral model in the rat whereby the abuse liability and pharmacologic profile of phencyclidine could be compared and contrasted qualitatively and quantitatively with various PCP analogues. Prominent behavioral effects of PCP in rodents are the mixed behavioral activation (stereotypy & locomotion) and ataxia. We have shown that these behavioral effects are dose-dependent and directly associated with characteristic shifts in the EEG power spectra. This EEG and behavioral profile in the rat is characteristic of drugs with psychotomimetic action in humans. The relevance of our EEG and behavioral model is supported by the fact that the cerebral cortex and hippocampus, which contribute mainly to the EEG effects of PCP in the rat and which are thought to be important in mediating many of the behavioral effects of PCP, contain high concentrations of PCP recep- tors. Moreover, the potency of analogues in this model corresponds to their potency and reinforcing efficacy in our rodent self-administration studies. Furthermore, distinctive effects on EEG spectral quantities were defined during self-administration of PCP and two analogues. Additional biological correlates were obtained of effects of self-administered PCP on regional brain 14C-2-deoxyglucose uptake in dopaminergic regions thought to mediate drug reinforcement. Subsequently, in preliminary studies haloperidol attenuated PCP self-administration. The objectives of this continuation proposal are to combine these behavioral, electrophysiologic and self-administration techniques to investigate the consequences of long-term administration of PCP, and to determine pharmacologic treatments which may attenuate PCP self-administration in the rat. We will characterize the development and expression of PCP tolerance and dependence; define receptor/neurotransmitter systems involved in development of tolerance, dependence and maintenance of PCP self-administration; and investigate possible pharmacologic interventions in PCP self-administration and relapse. These studies will, therefore, focus on the hallmarks of chronic drug abuse; tolerance, dependence, maintenance of drug seeking behavior and relapse. A clear definition of these phenomena and an understanding of the neuroanatomical, neurochemical and neurobehavioral bases will ultimately lead to improved methods of treatment and prevention of PCP abuse.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA003173-08
Application #
2116706
Study Section
Special Emphasis Panel (SRCD (26))
Project Start
1984-02-01
Project End
1994-01-31
Budget Start
1992-02-01
Budget End
1993-01-31
Support Year
8
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Hubner, C B; Moreton, J E (1991) Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology (Berl) 105:151-6
Marquis, K L; Paquette, N C; Gussio, R P et al. (1989) Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats. J Pharmacol Exp Ther 251:1104-12
Weissman, A D; Marquis, K L; Moreton, J E et al. (1989) Effects of self-administered phencyclidine on regional uptake of 2-deoxy-D-[1-14C]glucose in brain. Neuropharmacology 28:575-83
Marquis, K L; Webb, M G; Moreton, J E (1989) Effects of fixed ratio size and dose on phencyclidine self-administration by rats. Psychopharmacology (Berl) 97:179-82
Mattia, A; Marquis, K L; Leccese, A P et al. (1988) Electroencephalographic, behavioral and receptor binding correlates of phencyclinoids in the rat. J Pharmacol Exp Ther 246:797-802
Marquis, K L; Moreton, J E (1987) Animal models of intravenous phencyclinoid self-administration. Pharmacol Biochem Behav 27:385-9
Mattia, A; el-Fakahany, E E; Moreton, J E (1986) Behavioral and receptor binding studies of phencyclidine (PCP) and lithium interaction in the rat. Life Sci 38:975-84
Leccese, A P; Marquis, K L; Mattia, A et al. (1986) The anticonvulsant and behavioral effects of phencyclidine and ketamine following chronic treatment in rats. Behav Brain Res 22:257-64
Mattia, A; Leccese, A P; Marquis, K L et al. (1986) Electroencephalographic (EEG), psychopharmacological, and receptor-binding profiles of 'phencyclinoids'. NIDA Res Monogr 64:94-111
Mattia, A; Moreton, J E (1986) Electroencephalographic (EEG), EEG power spectra, and behavioral correlates in rats given phencyclidine. Neuropharmacology 25:763-9

Showing the most recent 10 out of 11 publications